2-6. Complex PCI [TCTAP A-046] Everolimus- Versus Zotarolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions (From an IRIS-MAIN Registry Substudy)
Abstract Presenter
April 28
3:20 PM - 3:30 PM
Abstract Zone II, Level 3
2-8. Imaging & Physiology [TCTAP A-093] Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between 1st and 2nd Generation Drug-Eluting Stent
CardioVascular Research Foundation(CVRF)
2nd Floor, Asan Institute for Education & Research,
88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Business registration number: 215-82-06387
Copyright ¨Ï 2002 CVRF, Seoul, Korea. All rights reserved.